NYSE:CL - Colgate-Palmolive Stock Price, News, & Analysis

Get Started

$66.48 +1.03 (+1.57 %)

(As of 02/18/2019 04:00 PM ET)

Previous Close$65.45

Today's Range$65.80 - $66.5350

52-Week Range$57.41 - $72.61

Volume5.37 million shs

Average Volume4.60 million shs

Market Capitalization$57.66 billion

P/E Ratio22.38

Dividend Yield2.57%

Beta0.78

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products. It also provides pet nutrition products for everyday nutritional needs; a range of therapeutic products to manage disease conditions; and various products with natural ingredients. The company's principal global and regional trademarks include Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet, and Hill's Ideal Balance. It markets and sells its oral, personal and home care products to various retail and wholesale customers, and distributors; and pet nutrition products for dogs and cats through pet supply retailers and veterinarians. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Receive CL News and Ratings via Email

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Toilet preparations

Sub-IndustryHousehold Products

SectorConsumer Staples

Current SymbolNYSE:CL

Previous Symbol

CUSIP19416210

Webwww.colgate.comen-usenusoc

Phone212-310-2000

Debt

Debt-to-Equity RatioN/A

Current Ratio0.39

Quick Ratio0.26

Price-To-Earnings

Trailing P/E Ratio22.38

Forward P/E Ratio23.49

P/E Growth4.26

Sales & Book Value

Annual Sales$15.54 billion

Price / Sales3.71

Cash Flow$3.6052 per share

Price / Cash Flow18.44

Book Value$0.23 per share

Price / Book289.04

Profitability

EPS (Most Recent Fiscal Year)$2.97

Net Income$2.40 billion

Net Margins15.44%

Return on Equity25,268.29%

Return on Assets20.50%

Miscellaneous

Employees35,900

Outstanding Shares867,320,000

Market Cap$57.66 billion

OptionableOptionable

Colgate-Palmolive (NYSE:CL) Frequently Asked Questions

What is Colgate-Palmolive's stock symbol?

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive declared a quarterly dividend on Thursday, January 10th. Investors of record on Wednesday, January 23rd will be given a dividend of $0.42 per share on Friday, February 15th. This represents a $1.68 dividend on an annualized basis and a yield of 2.53%. The ex-dividend date is Tuesday, January 22nd. View Colgate-Palmolive's Dividend History.

How will Colgate-Palmolive's stock buyback program work?

Colgate-Palmolive announced that its board has approved a share repurchase program on Monday, June 18th 2018, which permits the company to repurchase $5,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 9% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's board believes its stock is undervalued.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) posted its earnings results on Friday, January, 25th. The company reported $0.74 EPS for the quarter, beating the Zacks' consensus estimate of $0.73 by $0.01. The firm earned $3.81 billion during the quarter, compared to analysts' expectations of $3.78 billion. Colgate-Palmolive had a net margin of 15.44% and a return on equity of 25,268.29%. The company's revenue for the quarter was down 2.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.75 EPS. View Colgate-Palmolive's Earnings History.

When is Colgate-Palmolive's next earnings date?

Colgate-Palmolive is scheduled to release their next quarterly earnings announcement on Friday, April 26th 2019. View Earnings Estimates for Colgate-Palmolive.

How can I listen to Colgate-Palmolive's earnings call?

Colgate-Palmolive will be holding an earnings conference call on Friday, April 26th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link.

What price target have analysts set for CL?

16 Wall Street analysts have issued twelve-month price objectives for Colgate-Palmolive's stock. Their predictions range from $54.00 to $73.00. On average, they anticipate Colgate-Palmolive's share price to reach $65.1333 in the next year. This suggests that the stock has a possible downside of 2.0%. View Analyst Price Targets for Colgate-Palmolive.

What is the consensus analysts' recommendation for Colgate-Palmolive?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 1 sell rating, 11 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Colgate-Palmolive.

What are Wall Street analysts saying about Colgate-Palmolive stock?

Here are some recent quotes from research analysts about Colgate-Palmolive stock:

1. Jefferies Financial Group Inc analysts commented, "We maintain our Hold / $61 PT following the Colgate Total relaunch event in NYC (1/31). Despite clinical advances, significant investment, and improved price/mix, we are less certain the brand is a game changer given consumers’ shift from total care toothpaste products and relatively indistinguishable packaging vs. the existing brand. The stock’s recent bounce leaves valuation full at 22.5x NTM P/E (in-line w/hist. 5% prem. to HPC stocks) – Hold. We attended the Colgate Total re-launch event in NYC (1/31), which was primarily targeted toward media and valued product influencers, that sets the stage for the brand’s official roll-out. We are less certain this is a game-changer as total claim toothpaste brands have lost share in the US and the product’s packaging is relatively indistinguishable vs. its existing namesake product (see Chart 1)." (2/1/2019)
2. Wells Fargo & Co analysts commented, "We especially enjoyed the surprise performance by JoJo and sneak peek at CL’s Super Bowl ad featuring Luke Wilson. We also spent time in CL’s innovation area and saw firsthand the benefits of CL’s extensive R&D including anti-sensitivity, instant neutralization of odors, incremental enamel protection and new flavors. It also helped us conceptualize the significant marketing and promotional support that the brand will receive and as such, we came away feeling better about the potential for success of the Total relaunch. However, we also note that the uptick in spending CL is taking across its entire portfolio to accelerate organic sales growth (we est. +80bps) is also pressuring EPS (which is expected to be down -MSD in FY19)." (1/31/2019)
3. According to Zacks Investment Research, "Colgate lagged the industry in the past month due to a bleak earnings outlook for 2019. The company expects strong sales growth in 2019 backed by accelerated investments in brands, higher pricing and strong innovation. However, earnings are likely to be soft owing higher raw material costs, increase in tax rate, and uncertainties in the global markets and currency rates. Colgate reported top and bottom line beat in fourth-quarter 2018, retaining its meet or beat earnings track record. Meanwhile, earnings and sales dipped year over year marred by unfavorable currency rates. Additionally, the company continued its soft margins trend, which is likely to persist in 2019. Nonetheless, favorable pricing aided organic sales growth in the fourth quarter, which should sustain in 2019. Furthermore, its innovation efforts marked by the re-launch of Colgate Total and Hill’s Science Diet, as well as expansion of the naturals range, remain impressive." (1/30/2019)

Has Colgate-Palmolive been receiving favorable news coverage?

News headlines about CL stock have trended positive on Monday, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Colgate-Palmolive earned a news impact score of 2.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the stock's share price in the near term.

Who are some of Colgate-Palmolive's key competitors?

Some companies that are related to Colgate-Palmolive include Estee Lauder Companies (EL), Coty (COTY), Pola Orbis (PORBF), HYPERA S A/S (HYPMY), Edgewell Personal Care (EPC), Inter Parfums (IPAR), Revlon (REV), Mandom (MDOMF), Avon Products (AVP), e.l.f. Beauty (ELF), United-Guardian (UG), DS Healthcare Group (DSKX) and 2050 Motors (ETFM).

Who are Colgate-Palmolive's key executives?

Colgate-Palmolive's management team includes the folowing people:

Mr. Ian M. Cook, Chairman & CEO (Age 65)
Mr. Noel R. Wallace, Pres & COO (Age 54)
Mr. Dennis J. Hickey, Vice Chairman (Age 70)
Mr. Franck J. Moison, Vice Chairman (Age 64)
Mr. P. Justin Skala, Exec. VP and Chief Growth & Strategy Officer (Age 58)

Who are Colgate-Palmolive's major shareholders?

Colgate-Palmolive's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.99%), Massachusetts Financial Services Co. MA (3.75%), Bank of New York Mellon Corp (2.19%), Northern Trust Corp (1.24%), Geode Capital Management LLC (1.22%) and Oregon Public Employees Retirement Fund (0.65%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Philip G Shotts, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.

Which major investors are selling Colgate-Palmolive stock?

CL stock was sold by a variety of institutional investors in the last quarter, including Fundsmith LLP, Bank of New York Mellon Corp, Amundi Pioneer Asset Management Inc., CIBC Private Wealth Group LLC, Two Sigma Advisers LP, Eaton Vance Management, Robeco Institutional Asset Management B.V. and Voloridge Investment Management LLC. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Dennis J Hickey, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin and Philip G Shotts. View Insider Buying and Selling for Colgate-Palmolive.

Which major investors are buying Colgate-Palmolive stock?

CL stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Oregon Public Employees Retirement Fund, Ceredex Value Advisors LLC, Los Angeles Capital Management & Equity Research Inc., Massachusetts Financial Services Co. MA, Assenagon Asset Management S.A., Geode Capital Management LLC and Thrivent Financial for Lutherans. View Insider Buying and Selling for Colgate-Palmolive.

How do I buy shares of Colgate-Palmolive?

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Colgate-Palmolive's stock price today?

One share of CL stock can currently be purchased for approximately $66.48.

How big of a company is Colgate-Palmolive?

Colgate-Palmolive has a market capitalization of $57.66 billion and generates $15.54 billion in revenue each year. The company earns $2.40 billion in net income (profit) each year or $2.97 on an earnings per share basis. Colgate-Palmolive employs 35,900 workers across the globe.

What is Colgate-Palmolive's official website?

The official website for Colgate-Palmolive is http://www.colgate.com/en-us/en/us/oc.

How can I contact Colgate-Palmolive?

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]

MarketBeat Community Rating for Colgate-Palmolive (NYSE CL)

Community Ranking:		1.6 out of 5 ()
Outperform Votes:		374 (Vote Outperform)
Underperform Votes:		767 (Vote Underperform)
Total Votes:		1,141

MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 2/18/2019 by MarketBeat.com Staff